Business Context and Reporting Period
This Form 8-K was filed by HC2 Holdings, Inc. (HC2) on December 30, 2020, reporting a material definitive agreement entered into on the same date. The filing discloses the sale of HC2's majority-owned subsidiary, Beyond6, Inc., to an affiliate of Mercuria Investments US, Inc.
Key Financial Metrics and Transaction Terms
- Base Purchase Price: Approximately $169.0 million payable to Beyond6 equity holders at closing, net of debt and transaction expenses.
- Expected Net Proceeds to HC2: Approximately $65.0 million in cash, subject to customary closing adjustments.
- Use of Proceeds: HC2 intends to use the net proceeds to reduce debt.
- Reverse Termination Fee: $12.7125 million payable by the buyer (Parent) to Beyond6 if the agreement is terminated under specific circumstances.
- Financing: The buyer has obtained equity financing from Mercuria Investments US, Inc. to fund the cash portion of the purchase price.
Material Changes and Transaction Structure
The transaction involves a merger where Greenfill Merger, Inc. (Merger Sub) will merge with and into Beyond6, with Beyond6 surviving as a wholly-owned subsidiary of Greenfill, Inc. (Parent). The deal requires stockholder approval, which has been obtained, and is subject to customary closing conditions including antitrust clearance (Hart-Scott-Rodino waiting period). The filing does not provide comparative financial metrics (revenue, profit, margins) for HC2 or Beyond6, as this is a transaction announcement rather than a periodic financial report.
Outlook, Risks, and Contingencies
- Closing Timeline: Expected to close in the first quarter of 2021, but not earlier than January 22, 2021.
- Termination Rights: Either party may terminate if the closing does not occur by March 1, 2021, unless the delay is caused by a breach by the terminating party.
- Management Retention: Andrew West, CEO of Beyond6, has agreed to rollover certain securities and enter into an employment agreement with the buyer's affiliate.
- Risk Factors: Closing is contingent on regulatory approvals and the absence of laws prohibiting the transaction. The filing explicitly states that representations and warranties in the Merger Agreement are not characterizations of actual facts and should not be relied upon as such.
Investor Verification Checklist
- Verify the final closing date and whether the transaction closes in Q1 2021 as expected.
- Confirm the actual net cash proceeds received by HC2 after debt paydown and transaction expenses.
- Monitor regulatory filings for any antitrust challenges or conditions imposed by the Hart-Scott-Rodino review.
- Review HC2's subsequent filings to confirm the specific debt reduction strategy and impact on the balance sheet.
- Check for any updates regarding the $12.7125 million reverse termination fee obligation if the deal fails to close.